vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与UNIVEST FINANCIAL Corp（UVSP）财务数据对比。点击上方公司名可切换其他公司
UNIVEST FINANCIAL Corp的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$87.5M vs $75.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 10.2%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Univest Financial Corp是总部位于美国宾夕法尼亚州的区域金融服务控股公司，面向大西洋中部地区的个人消费者、中小企业及机构客户提供银行、财富管理、保险、信贷等多元化金融产品与服务。
PBYI vs UVSP — 直观对比
营收规模更大
UVSP
是对方的1.2倍
$75.5M
两年增速更快
PBYI
近两年复合增速
10.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $87.5M |
| 净利润 | — | $27.1M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | 31.0% |
| 营收同比 | 27.7% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.26 | $0.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIUVSP
| Q1 26 | — | $87.5M | ||
| Q4 25 | $75.5M | $84.6M | ||
| Q3 25 | $54.5M | $83.2M | ||
| Q2 25 | $52.4M | $81.0M | ||
| Q1 25 | $46.0M | $79.2M | ||
| Q4 24 | $59.1M | $76.8M | ||
| Q3 24 | $80.5M | $73.4M | ||
| Q2 24 | $47.1M | $72.0M |
净利润PBYIUVSP
| Q1 26 | — | $27.1M | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | $8.8M | $25.6M | ||
| Q2 25 | $5.9M | $20.0M | ||
| Q1 25 | $3.0M | $22.4M | ||
| Q4 24 | — | $18.9M | ||
| Q3 24 | $20.3M | $18.6M | ||
| Q2 24 | $-4.5M | $18.1M |
毛利率PBYIUVSP
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
营业利润率PBYIUVSP
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | 34.0% | ||
| Q3 25 | 17.6% | 38.5% | ||
| Q2 25 | 12.7% | 30.9% | ||
| Q1 25 | 8.7% | 34.8% | ||
| Q4 24 | 22.6% | 30.9% | ||
| Q3 24 | 27.4% | 31.9% | ||
| Q2 24 | -4.6% | 31.4% |
净利率PBYIUVSP
| Q1 26 | — | 31.0% | ||
| Q4 25 | — | 26.9% | ||
| Q3 25 | 16.2% | 30.8% | ||
| Q2 25 | 11.2% | 24.7% | ||
| Q1 25 | 6.5% | 28.3% | ||
| Q4 24 | — | 24.7% | ||
| Q3 24 | 25.2% | 25.3% | ||
| Q2 24 | -9.6% | 25.1% |
每股收益（稀释后）PBYIUVSP
| Q1 26 | — | $0.96 | ||
| Q4 25 | $0.26 | $0.78 | ||
| Q3 25 | $0.17 | $0.89 | ||
| Q2 25 | $0.12 | $0.69 | ||
| Q1 25 | $0.06 | $0.77 | ||
| Q4 24 | $0.40 | $0.64 | ||
| Q3 24 | $0.41 | $0.63 | ||
| Q2 24 | $-0.09 | $0.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $222.4M |
| 总债务越低越好 | $22.7M | $201.2M |
| 股东权益账面价值 | $130.3M | $952.0M |
| 总资产 | $216.3M | $8.1B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资PBYIUVSP
| Q1 26 | — | $222.4M | ||
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — |
总债务PBYIUVSP
| Q1 26 | — | $201.2M | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
股东权益PBYIUVSP
| Q1 26 | — | $952.0M | ||
| Q4 25 | $130.3M | $943.3M | ||
| Q3 25 | $115.3M | $933.2M | ||
| Q2 25 | $104.7M | $916.7M | ||
| Q1 25 | $97.1M | $903.5M | ||
| Q4 24 | $92.1M | $887.3M | ||
| Q3 24 | $71.1M | $877.1M | ||
| Q2 24 | $48.5M | $854.1M |
总资产PBYIUVSP
| Q1 26 | — | $8.1B | ||
| Q4 25 | $216.3M | $8.4B | ||
| Q3 25 | $202.9M | $8.6B | ||
| Q2 25 | $194.9M | $7.9B | ||
| Q1 25 | $196.2M | $8.0B | ||
| Q4 24 | $213.3M | $8.1B | ||
| Q3 24 | $220.7M | $8.2B | ||
| Q2 24 | $205.0M | $7.9B |
负债/权益比PBYIUVSP
| Q1 26 | — | 0.21× | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | — |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIUVSP
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $101.5M | ||
| Q3 25 | $9.7M | $32.0M | ||
| Q2 25 | $14.1M | $23.3M | ||
| Q1 25 | $3.6M | $15.6M | ||
| Q4 24 | $15.6M | $75.1M | ||
| Q3 24 | $11.0M | $38.9M | ||
| Q2 24 | $1.0M | $-3.4M |
自由现金流PBYIUVSP
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $96.9M | ||
| Q3 25 | $9.7M | $31.4M | ||
| Q2 25 | $14.1M | $21.9M | ||
| Q1 25 | $3.6M | $13.7M | ||
| Q4 24 | $15.6M | $72.0M | ||
| Q3 24 | $11.0M | $38.3M | ||
| Q2 24 | $1.0M | $-4.2M |
自由现金流率PBYIUVSP
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 114.6% | ||
| Q3 25 | 17.7% | 37.7% | ||
| Q2 25 | 26.8% | 27.0% | ||
| Q1 25 | 7.7% | 17.2% | ||
| Q4 24 | 26.4% | 93.8% | ||
| Q3 24 | 13.7% | 52.2% | ||
| Q2 24 | 2.1% | -5.9% |
资本支出强度PBYIUVSP
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 5.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 1.7% | ||
| Q1 25 | 0.1% | 2.5% | ||
| Q4 24 | 0.0% | 4.0% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 1.1% |
现金转化率PBYIUVSP
| Q1 26 | — | — | ||
| Q4 25 | — | 4.46× | ||
| Q3 25 | 1.10× | 1.25× | ||
| Q2 25 | 2.41× | 1.16× | ||
| Q1 25 | 1.21× | 0.70× | ||
| Q4 24 | — | 3.97× | ||
| Q3 24 | 0.54× | 2.09× | ||
| Q2 24 | — | -0.19× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
UVSP
| Net Interest Income | $63.4M | 72% |
| Noninterest Income | $24.1M | 28% |
